Search

everythinglearnresearchcommunity

for

Search:↓

Hair restoration surgery can be safely done without major bleeding in patients on antithrombotic therapy, and these drugs shouldn't be stopped before surgery.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Men with androgenetic alopecia may have a higher risk of heart rhythm problems.

Hair loss in young adults is linked to harder arteries.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

New compounds may help treat heart disease by activating specific potassium channels.

A man developed heart problems after using a baldness treatment for 4 months, suggesting that people with heart issues should avoid this treatment.

Warfarin is effective but risky, requiring careful monitoring to prevent bleeding.

Bridging anticoagulation may raise post-surgery bleeding risks.

Thyroid dysfunction can cause heart issues, and bedside ultrasound helps diagnose cardiac arrest causes.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Off-pump heart surgery reduces complications without affecting survival rates compared to on-pump surgery.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Alopecia areata does not increase the risk of blood clots.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Men with male pattern baldness have increased arterial stiffness.

Reduced plakoglobin and steroid abuse increase the risk of heart rhythm issues.

Male hormones and reduced plakoglobin can impair heart electrical function and increase arrhythmia risk in males.

Mice with autoimmune hair loss showed signs of heart problems.

A dog with a rare heart clot died despite treatment, highlighting the need for better clot treatments in dogs.